Charles River/$CRL
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About Charles River
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Ticker
$CRL
Sector
Primary listing
NYSE
Employees
19,400
Headquarters
Website
Charles River Metrics
BasicAdvanced
$8.2B
-
-$1.37
1.50
-
Price and volume
Market cap
$8.2B
Beta
1.5
52-week high
$217.00
52-week low
$91.86
Average daily volume
942K
Financial strength
Current ratio
1.36
Quick ratio
0.88
Long term debt to equity
81.952
Total debt to equity
82.039
Interest coverage (TTM)
4.99%
Profitability
EBITDA (TTM)
955.694
Gross margin (TTM)
35.03%
Net profit margin (TTM)
-1.66%
Operating margin (TTM)
13.28%
Effective tax rate (TTM)
-257.39%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
4.68%
Return on equity (TTM)
-1.81%
Valuation
Price to revenue (TTM)
2.097
Price to book
2.45
Price to tangible book (TTM)
-44.33
Price to free cash flow (TTM)
14.607
Free cash flow yield (TTM)
6.85%
Free cash flow per share (TTM)
11.435
Growth
Revenue change (TTM)
-1.21%
Earnings per share change (TTM)
-116.46%
3-year revenue growth (CAGR)
2.99%
10-year revenue growth (CAGR)
11.83%
3-year earnings per share growth (CAGR)
-45.74%
10-year earnings per share growth (CAGR)
-7.30%
What the Analysts think about Charles River
Analyst ratings (Buy, Hold, Sell) for Charles River stock.
Bulls say / Bears say
Second-quarter revenue rose to $1.032 billion, an increase of 0.6% year-over-year, and non-GAAP EPS climbed 11.4% to $3.12, boosted by improved operating margins in all divisions (Business Wire)
The company raised its full-year 2025 revenue and non-GAAP EPS guidance after better-than-expected Q2 results, reflecting management’s confidence in stronger market conditions (Business Wire)
U.S. Department of Justice concluded both grand jury and civil investigations into Charles River’s non-human primate supply chain, eliminating a major legal uncertainty (Business Wire)
Discovery & Safety Assessment segment’s organic revenue declined 2.4% year-over-year in Q2, indicating ongoing weak demand for Charles River’s key drug discovery services (Business Wire)
Manufacturing Solutions segment’s GAAP operating margin fell sharply to 6.0% from 19.4% year-over-year in Q2, due to accelerated amortization of CDMO client relationships, exposing volatility in segment profitability (Business Wire)
The agreement with Elliott Investment Management to appoint four new directors and conduct a strategic review signals ongoing governance issues and uncertainty around the company’s strategic direction (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2025.
Charles River Financial Performance
Revenues and expenses
Charles River Earnings Performance
Company profitability
Charles River News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Charles River stock?
Charles River (CRL) has a market cap of $8.2B as of October 13, 2025.
What is the P/E ratio for Charles River stock?
The price to earnings (P/E) ratio for Charles River (CRL) stock is 0 as of October 13, 2025.
Does Charles River stock pay dividends?
No, Charles River (CRL) stock does not pay dividends to its shareholders as of October 13, 2025.
When is the next Charles River dividend payment date?
Charles River (CRL) stock does not pay dividends to its shareholders.
What is the beta indicator for Charles River?
Charles River (CRL) has a beta rating of 1.5. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.